[1]
K. N. Sobirdjanovna, J. Yusufbek, O. Suhrob, O. Jamshid, and O. Dilorom, “Features of Use of Combined Glow-Lowing Therapy in Patients with Type 2 Diabetes and IHD”, JSML, vol. 2, no. 4, pp. 40–44, Apr. 2024.